NHS breast screening programme: Is the high incidence of interval cancers inevitable?

BMJ

Volumn 313, Issue 7069, 1996, Pages 1369-1370

  Asbury, David ^a   Boggis, Caroline R M ^a   Sheals, David ^b   Threlfall, Anthony G ^c   Woodman, Ciaran B J ^c  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b ROYAL ALBERT EDWARD INFIRMARY   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL;

BREAST NEOPLASMS; ENGLAND; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 0029798893     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7069.1369     Document Type: Article

References (5)

1. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P. Is the three year breast screening interval too long? The occurrence of interval cancers in the north west region of the NHS breast screening programme. BMJ 1995; 310: 224–226.
2. Day N, McCann J, Camilleri-Ferrante C, Britton P, Cush S, Hurst G,, et al. Monitoring interval cancers in breast screening programmes: the East Anglian experience. Journal of Medical Screening 1995; 2: 180–185.
3. Field S, Michell MJ, Wallis MGW, Wilson ARM. What should be done about interval breast cancers? BMJ 1995; 310: 203–204.
4. Peeters PHM, Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 1989; 59: 929–932.
5. Frisell J, von Rosen A, Wiege M, Nilsson B, Goldman S. Interval cancer and survival in a randomised breast cancer screening trial in Stockholm. Breast Cancer Research and Treatment 1992; 24: 11–16.